Natural coagulation inhibitors and active protein c resistance in preeclampsia

INTRODUCTION: The etiology of preeclampsia is not fully established. A few studies have shown a relationship between natural coagulation inhibitors and preeclampsia. OBJECTIVES: The purpose of this study was to investigate the status of natural coagulation inhibitors and active protein C resistance...

Full description

Bibliographic Details
Main Authors: Cengiz Demir, Imdat Dilek
Format: Article
Language:English
Published: Elsevier España 2010-01-01
Series:Clinics
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322010001100011
_version_ 1818112917592080384
author Cengiz Demir
Imdat Dilek
author_facet Cengiz Demir
Imdat Dilek
author_sort Cengiz Demir
collection DOAJ
description INTRODUCTION: The etiology of preeclampsia is not fully established. A few studies have shown a relationship between natural coagulation inhibitors and preeclampsia. OBJECTIVES: The purpose of this study was to investigate the status of natural coagulation inhibitors and active protein C resistance (APC-R) in preeclampsia. PATIENTS AND METHODS: We studied 70 women with preeclampsia recruited consecutively and 70 healthy pregnant and 70 nonpregnant women as controls. Plasma protein C (PC), free protein S (fPS), antithrombin III (ATIII) and APC-R were evaluated. RESULTS: ATIII values were found to be significantly lower in preeclamptic patients than in the control groups (p< 0.001). Nevertheless, there was no significant difference between the healthy pregnant and nonpregnant women groups (p=0.141). The fPS values of the preeclamptic and healthy pregnant groups were lower than that of the nonpregnant group (p< 0.001), and the fPS value of the preeclamptic pregnant women was lower than that of healthy pregnant women (p<0.001). The PC value of the preeclamptic pregnant women was lower than that of the control groups (p< 0.001). The PC value of the healthy pregnant women was lower than that of the nonpregnant women (p< 0.001). The mean APC activity values were lower in the preeclamptic patients than that of the control groups (p< 0.001, p< 0.001). The APC-R positivity rates of the preeclamptic groups were higher than that of the control groups (p<0.001). CONCLUSIONS: This study demonstrated that ATIII, fPS, PC values and APC resistance were lower and APC-R positivity was higher in preeclamptic women than in normal pregnant and nonpregnant women.
first_indexed 2024-12-11T03:26:33Z
format Article
id doaj.art-45b6701dedf141c3a5d4ba02c1fa2a83
institution Directory Open Access Journal
issn 1807-5932
1980-5322
language English
last_indexed 2024-12-11T03:26:33Z
publishDate 2010-01-01
publisher Elsevier España
record_format Article
series Clinics
spelling doaj.art-45b6701dedf141c3a5d4ba02c1fa2a832022-12-22T01:22:30ZengElsevier EspañaClinics1807-59321980-53222010-01-0165111119112210.1590/S1807-59322010001100011Natural coagulation inhibitors and active protein c resistance in preeclampsiaCengiz DemirImdat DilekINTRODUCTION: The etiology of preeclampsia is not fully established. A few studies have shown a relationship between natural coagulation inhibitors and preeclampsia. OBJECTIVES: The purpose of this study was to investigate the status of natural coagulation inhibitors and active protein C resistance (APC-R) in preeclampsia. PATIENTS AND METHODS: We studied 70 women with preeclampsia recruited consecutively and 70 healthy pregnant and 70 nonpregnant women as controls. Plasma protein C (PC), free protein S (fPS), antithrombin III (ATIII) and APC-R were evaluated. RESULTS: ATIII values were found to be significantly lower in preeclamptic patients than in the control groups (p< 0.001). Nevertheless, there was no significant difference between the healthy pregnant and nonpregnant women groups (p=0.141). The fPS values of the preeclamptic and healthy pregnant groups were lower than that of the nonpregnant group (p< 0.001), and the fPS value of the preeclamptic pregnant women was lower than that of healthy pregnant women (p<0.001). The PC value of the preeclamptic pregnant women was lower than that of the control groups (p< 0.001). The PC value of the healthy pregnant women was lower than that of the nonpregnant women (p< 0.001). The mean APC activity values were lower in the preeclamptic patients than that of the control groups (p< 0.001, p< 0.001). The APC-R positivity rates of the preeclamptic groups were higher than that of the control groups (p<0.001). CONCLUSIONS: This study demonstrated that ATIII, fPS, PC values and APC resistance were lower and APC-R positivity was higher in preeclamptic women than in normal pregnant and nonpregnant women.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322010001100011Natural Coagulation InhibitorsAPC-RRiskPathogenesisPreeclampsia
spellingShingle Cengiz Demir
Imdat Dilek
Natural coagulation inhibitors and active protein c resistance in preeclampsia
Clinics
Natural Coagulation Inhibitors
APC-R
Risk
Pathogenesis
Preeclampsia
title Natural coagulation inhibitors and active protein c resistance in preeclampsia
title_full Natural coagulation inhibitors and active protein c resistance in preeclampsia
title_fullStr Natural coagulation inhibitors and active protein c resistance in preeclampsia
title_full_unstemmed Natural coagulation inhibitors and active protein c resistance in preeclampsia
title_short Natural coagulation inhibitors and active protein c resistance in preeclampsia
title_sort natural coagulation inhibitors and active protein c resistance in preeclampsia
topic Natural Coagulation Inhibitors
APC-R
Risk
Pathogenesis
Preeclampsia
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322010001100011
work_keys_str_mv AT cengizdemir naturalcoagulationinhibitorsandactiveproteincresistanceinpreeclampsia
AT imdatdilek naturalcoagulationinhibitorsandactiveproteincresistanceinpreeclampsia